Christian Behrenbruch, Director at Amplia Therapeutics Ltd., holds 23.23M shares in Telix Pharmaceuticals Ltd. (Ticker: TLPPF), holds 2.74M shares in Amplia Therapeutics Ltd. (Ticker: INNMF).

See the Hottest Stocks Based on Insider Trading >

Christian Behrenbruch
Amplia Therapeutics Ltd. (INNMF)
Director

Ranked #27,820 out of 98,624 Corporate Insiders

Profitable Transactions

1 out of 2 Profitable Transactions

Average Return

+65.80%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

99.94%

TLPPF

0.06%

INNMF

A breakdown of Christian Behrenbruch's holdings

See the Top Stocks by Insiders

Insider Roles

Telix Pharmaceuticals Ltd.
(TLPPF)

Managing Director & Chief Executive Officer

Amplia Therapeutics Ltd.
(INNMF)

Director

Roles that Christian Behrenbruch holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Amplia Therapeutics Ltd.
(INNMF)

Rating:Informative Buy

Date:Sep 17, 2019 - Sep 17, 2020

Return:+132.60%

The most profitable trade made by Christian Behrenbruch

See the Latest Stocks Traded by Insiders

Christian Behrenbruch's Trading History

INNMF

Amplia Therapeutics Ltd.

Sep 17, 2019

Director

Informative Buy

25.00K

$137.11K

TLPPF

Telix Pharmaceuticals Ltd.

Jan 22, 2024

Managing Director & Chief Executive Officer

Uninformative Sell

―

$237.28M

List of latest transactions for each holding click on a transaction to see Christian Behrenbruch's performance on stock

See All Insider Trading from Today

Christian Behrenbruch insider profile FAQ

What is the percentage of profitable transactions made by Christian Behrenbruch?

The percentage of profitable transactions made by Christian Behrenbruch is 50%.

What is the average return per transaction made by Christian Behrenbruch?

The average return per transaction made by Christian Behrenbruch is 65.80%.

What stocks does Christian Behrenbruch hold?

Christian Behrenbruch holds: INNMF, TLPPF stocks.

What was Christian Behrenbruch’s latest transaction?

Christian Behrenbruch latest transaction was an Uninformative Sell of ―.

What was Christian Behrenbruch's most profitable transaction?

Christian Behrenbruch’s most profitable transaction was an Informative Buy of INNMF stock on September 17, 2019. The return on the trade was 132.60%.

What is Christian Behrenbruch's role in Amplia Therapeutics Ltd.?

Christian Behrenbruch's role in Amplia Therapeutics Ltd. is Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Christian Behrenbruch Insider Profile

Christian Behrenbruch Amplia Therapeutics Ltd. (INNMF)Director